|
Wed, 05/25/2022 - 19:49 |
GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHORESIS |
Bio-Techne |
|
Wed, 05/25/2022 - 11:24 |
GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHERESIS |
Bio-Techne |
|
Tue, 12/04/2018 - 16:52 |
Late-Breaking Clinical Trials Present Clinic-Ready Advances for Non-Malignant Diseases |
American Societ... |
|
Tue, 11/06/2018 - 02:04 |
U.S. Food and Drug Administration Approves Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone, a New Immunotherapy Combination for Certain Patients with Relapsed or Refractory Multiple Myeloma |
MMRF |
|
Tue, 10/30/2018 - 03:37 |
UMass Amherst Team Aims to Improve Accuracy in Sequencing Large Genomes |
University of M... |
|
Wed, 08/29/2018 - 14:43 |
Electronic device implanted in the brain could stop seizures |
University of C... |
|
Thu, 08/16/2018 - 15:54 |
Scientists discover why some people with brain markers of Alzheimers have no dementia |
UTMB |
|
Wed, 08/08/2018 - 02:37 |
Quantifying SF6 and PCBs With a Custom-Designed Nexis GC-2030 |
kdm communications |
|
Thu, 05/31/2018 - 13:16 |
Agilent Technologies Completes Acquisition of Advanced Analytical Technologies, Inc. |
Agilent |
|
Mon, 05/07/2018 - 05:01 |
Janssen Announces DARZALEX (daratumumab) U.S. FDA Approval for Newly Diagnosed Patients with Multiple Myeloma who are Transplant Ineligible |
Johnson and Johnson |
|
Fri, 04/27/2018 - 13:07 |
BD Names Three Executives to Segment Leadership Roles |
bd |
|
Wed, 03/07/2018 - 20:12 |
Agilent Technologies to Acquire Advanced Analytical Technologies, Inc. |
Agilent |
|
Tue, 12/19/2017 - 12:48 |
Powervar Security Plus UPS Showcased at SCIEX Customer Demonstration Facility |
AMETEK |
|
Tue, 12/12/2017 - 08:31 |
DARZALEX (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible |
Johnson and Johnson |
|
Mon, 12/11/2017 - 18:35 |
Early data evaluated subcutaneous delivery of DARZALEX in relapsed or refractory multiple myeloma (oral presentation; |
Johnson and Johnson |
|
Tue, 11/21/2017 - 14:54 |
Supplemental Biologics License Application (sBLA) seeks first indication for DARZALEX for the treatment of newly diagnosed patients |
Johnson and Johnson |
|
Fri, 09/01/2017 - 16:20 |
A technology developed by UAlberta engineers could lead to a dramatic cost reduction for medical and pharmaceutical researchers to detect various types of proteins, used to develop drugs. |
University of A... |
|
Thu, 08/31/2017 - 22:04 |
New technology could reduce costs significantly in protein analysis during drug development |
University of A... |
|
Mon, 06/26/2017 - 18:34 |
Battelle Releases Results of NIJ Study of MPS Forensic Methods |
Battelle |
|
Thu, 06/15/2017 - 22:24 |
DARZALEX (daratumumab) Approved by the U.S. FDA in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma Who Have Received At Least Two Prior Therapies |
Johnson and Johnson |
|
Sun, 06/04/2017 - 09:58 |
Daratumumab Combination Therapy Improved Clinical Outcomes Regardless of Cytogenetic Risk for Previously-Treated Patients with Multiple Myeloma |
Johnson and Johnson |
|
Tue, 05/16/2017 - 10:44 |
Scientists develop automated blood test for chronic liver disease |
University of Ghent |
|
Tue, 04/04/2017 - 02:49 |
METTLER TOLEDO Launches On-line Chloride/Sulfate Analyzer |
METTLER TOLEDO |
|
Wed, 03/15/2017 - 01:24 |
Biocartis receives grant for development of a fully automated MSI test |
FlandersBio |
|
Wed, 02/08/2017 - 09:12 |
CZ Biohub awards nearly $14.5 million to Berkeley researchers |
University of B... |
